{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T23:00:39Z","timestamp":1771801239610,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2015,10,31]],"date-time":"2015-10-31T00:00:00Z","timestamp":1446249600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"UCSF Research Allocation Program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1007\/s10549-015-3610-1","type":"journal-article","created":{"date-parts":[[2015,10,31]],"date-time":"2015-10-31T05:07:10Z","timestamp":1446268030000},"page":"339-349","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Detection of cerebrospinal fluid tumor cells and its clinical relevance in leptomeningeal metastasis of breast cancer"],"prefix":"10.1007","volume":"154","author":[{"given":"Jin Sun","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle E.","family":"Melisko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark Jesus M.","family":"Magbanua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea T.","family":"Kablanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet H.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hope S.","family":"Rugo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John W.","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,31]]},"reference":[{"issue":"4","key":"3610_CR1","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1055\/s-2004-861531","volume":"24","author":"MC Chamberlain","year":"2004","unstructured":"Chamberlain MC (2004) Neoplastic meningitis. Semin Neurol 24(4):363\u2013374. doi: 10.1055\/s-2004-861531","journal-title":"Semin Neurol"},{"issue":"2","key":"3610_CR2","first-page":"117","volume":"3","author":"BJ Scott","year":"2013","unstructured":"Scott BJ, Kesari S (2013) Leptomeningeal metastases in breast cancer. Am J Cancer Res 3(2):117\u2013126","journal-title":"Am J Cancer Res"},{"issue":"18","key":"3610_CR3","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1212\/WNL.0b013e3181dc1a69","volume":"74","author":"JL Clarke","year":"2010","unstructured":"Clarke JL, Perez HR, Jacks LM, Panageas KS, Deangelis LM (2010) Leptomeningeal metastases in the MRI era. Neurology 74(18):1449\u20131454. doi: 10.1212\/WNL.0b013e3181dc1a69","journal-title":"Neurology"},{"issue":"11","key":"3610_CR4","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1038\/bjc.2012.163","volume":"106","author":"G Frisk","year":"2012","unstructured":"Frisk G, Svensson T, Backlund LM, Lidbrink E, Blomqvist P, Smedby KE (2012) Incidence and time trends of brain metastases admissions among breast cancer patients in Sweden. Br J Cancer 106(11):1850\u20131853. doi: 10.1038\/bjc.2012.163","journal-title":"Br J Cancer"},{"issue":"6","key":"3610_CR5","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1158\/1078-0432.CCR-06-2478","volume":"13","author":"NU Lin","year":"2007","unstructured":"Lin NU, Winer EP (2007) Brain metastases: the HER2 paradigm. Clin Cancer Res 13(6):1648\u20131655. doi: 10.1158\/1078-0432.CCR-06-2478","journal-title":"Clin Cancer Res"},{"issue":"12","key":"3610_CR6","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1002\/cncr.23088","volume":"110","author":"K Altundag","year":"2007","unstructured":"Altundag K, Bondy ML, Mirza NQ, Kau SW, Broglio K, Hortobagyi GN, Rivera E (2007) Clinicopathologic characteristics and prognostic factors in 420 metastatic breast cancer patients with central nervous system metastasis. Cancer 110(12):2640\u20132647. doi: 10.1002\/cncr.23088","journal-title":"Cancer"},{"issue":"2","key":"3610_CR7","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s11060-011-0664-8","volume":"106","author":"HJ Kim","year":"2012","unstructured":"Kim HJ, Im SA, Keam B, Kim YJ, Han SW, Kim TM, Oh DY, Kim JH, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Noh DY, Heo DS, Park IA, Bang YJ, Ha SW (2012) Clinical outcome of central nervous system metastases from breast cancer: differences in survival depending on systemic treatment. J Neuro-oncol 106(2):303\u2013313. doi: 10.1007\/s11060-011-0664-8","journal-title":"J Neuro-oncol"},{"issue":"11","key":"3610_CR8","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1093\/annonc\/mdq232","volume":"21","author":"H Gauthier","year":"2010","unstructured":"Gauthier H, Guilhaume MN, Bidard FC, Pierga JY, Girre V, Cottu PH, Laurence V, Livartowski A, Mignot L, Dieras V (2010) Survival of breast cancer patients with meningeal carcinomatosis. Ann Oncol 21(11):2183\u20132187. doi: 10.1093\/annonc\/mdq232","journal-title":"Ann Oncol"},{"issue":"2","key":"3610_CR9","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s11060-010-0524-y","volume":"104","author":"CR Azevedo de","year":"2011","unstructured":"de Azevedo CR, Cruz MR, Chinen LT, Peres SV, Peterlevitz MA, de Azevedo Pereira AE, Fanelli MF, Gimenes DL (2011) Meningeal carcinomatosis in breast cancer: prognostic factors and outcome. J Neuro-oncol 104(2):565\u2013572. doi: 10.1007\/s11060-010-0524-y","journal-title":"J Neuro-oncol"},{"issue":"3","key":"3610_CR10","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1200\/JCO.1993.11.3.561","volume":"11","author":"SA Grossman","year":"1993","unstructured":"Grossman SA, Finkelstein DM, Ruckdeschel JC, Trump DL, Moynihan T, Ettinger DS (1993) Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group. J Clin Oncol 11(3):561\u2013569","journal-title":"J Clin Oncol"},{"issue":"3","key":"3610_CR11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1023\/A:1005976926058","volume":"37","author":"MC Chamberlain","year":"1998","unstructured":"Chamberlain MC (1998) Leptomeningeal metastases: a review of evaluation and treatment. J Neurooncol 37(3):271\u2013284","journal-title":"J Neurooncol"},{"issue":"3","key":"3610_CR12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF02341153","volume":"9","author":"JG Kaplan","year":"1990","unstructured":"Kaplan JG, DeSouza TG, Farkash A, Shafran B, Pack D, Rehman F, Fuks J, Portenoy R (1990) Leptomeningeal metastases: comparison of clinical features and laboratory data of solid tumors, lymphomas and leukemias. J Neuro-oncol 9(3):225\u2013229","journal-title":"J Neuro-oncol"},{"issue":"7","key":"3610_CR13","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1001\/archneur.1996.00550070064013","volume":"53","author":"M Balm","year":"1996","unstructured":"Balm M, Hammack J (1996) Leptomeningeal carcinomatosis. Presenting features and prognostic factors. Arch Neurol 53(7):626\u2013632","journal-title":"Arch Neurol"},{"issue":"4","key":"3610_CR14","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/(SICI)1097-0142(19980215)82:4<733::AID-CNCR17>3.0.CO;2-Z","volume":"82","author":"MJ Glantz","year":"1998","unstructured":"Glantz MJ, Cole BF, Glantz LK, Cobb J, Mills P, Lekos A, Walters BC, Recht LD (1998) Cerebrospinal fluid cytology in patients with cancer: minimizing false-negative results. Cancer 82(4):733\u2013739","journal-title":"Cancer"},{"issue":"9","key":"3610_CR15","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1007\/s004150050459","volume":"246","author":"CS Straathof","year":"1999","unstructured":"Straathof CS, de Bruin HG, Dippel DW, Vecht CJ (1999) The diagnostic accuracy of magnetic resonance imaging and cerebrospinal fluid cytology in leptomeningeal metastasis. J Neurol 246(9):810\u2013814","journal-title":"J Neurol"},{"issue":"9","key":"3610_CR16","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/j.1468-1331.2006.01493.x","volume":"13","author":"F Deisenhammer","year":"2006","unstructured":"Deisenhammer F, Bartos A, Egg R, Gilhus NE, Giovannoni G, Rauer S, Sellebjerg F, Force ET (2006) Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force. Eur J Neurol 13(9):913\u2013922. doi: 10.1111\/j.1468-1331.2006.01493.x","journal-title":"Eur J Neurol"},{"issue":"4 Suppl 2","key":"3610_CR17","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1053\/j.seminoncol.2009.05.005","volume":"36","author":"MC Chamberlain","year":"2009","unstructured":"Chamberlain MC, Glantz M, Groves MD, Wilson WH (2009) Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment. Semin Oncol 36(4 Suppl 2):S35\u2013S45. doi: 10.1053\/j.seminoncol.2009.05.005","journal-title":"Semin Oncol"},{"issue":"20","key":"3610_CR18","doi-asserted-by":"crossref","first-page":"6897","DOI":"10.1158\/1078-0432.CCR-04-0378","volume":"10","author":"WJ Allard","year":"2004","unstructured":"Allard WJ, Matera J, Miller MC, Repollet M, Connelly MC, Rao C, Tibbe AG, Uhr JW, Terstappen LW (2004) Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 10(20):6897\u20136904","journal-title":"Clin Cancer Res"},{"issue":"7173","key":"3610_CR19","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/nature06385","volume":"450","author":"S Nagrath","year":"2007","unstructured":"Nagrath S, Sequist LV, Maheswaran S, Bell DW, Irimia D, Ulkus L, Smith MR, Kwak EL, Digumarthy S, Muzikansky A, Ryan P, Balis UJ, Tompkins RG, Haber DA, Toner M (2007) Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 450(7173):1235\u20131239. doi: 10.1038\/nature06385","journal-title":"Nature"},{"issue":"8","key":"3610_CR20","first-page":"3507","volume":"32","author":"T Todenhofer","year":"2012","unstructured":"Todenhofer T, Hennenlotter J, Feyerabend S, Aufderklamm S, Mischinger J, Kuhs U, Gerber V, Fetisch J, Schilling D, Hauch S, Stenzl A, Schwentner C (2012) Preliminary experience on the use of the Adnatest(R) system for detection of circulating tumor cells in prostate cancer patients. Anticancer Res 32(8):3507\u20133513","journal-title":"Anticancer Res"},{"issue":"22","key":"3610_CR21","doi-asserted-by":"crossref","first-page":"6980","DOI":"10.1158\/1078-0432.CCR-09-1095","volume":"15","author":"F Tanaka","year":"2009","unstructured":"Tanaka F, Yoneda K, Kondo N, Hashimoto M, Takuwa T, Matsumoto S, Okumura Y, Rahman S, Tsubota N, Tsujimura T, Kuribayashi K, Fukuoka K, Nakano T, Hasegawa S (2009) Circulating tumor cell as a diagnostic marker in primary lung cancer. Clin Cancer Res 15(22):6980\u20136986. doi: 10.1158\/1078-0432.CCR-09-1095","journal-title":"Clin Cancer Res"},{"issue":"2","key":"3610_CR22","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/annonc\/mdn627","volume":"20","author":"DJ Gallagher","year":"2009","unstructured":"Gallagher DJ, Milowsky MI, Ishill N, Trout A, Boyle MG, Riches J, Fleisher M, Bajorin DF (2009) Detection of circulating tumor cells in patients with urothelial cancer. Ann Oncol 20(2):305\u2013308. doi: 10.1093\/annonc\/mdn627","journal-title":"Ann Oncol"},{"issue":"23","key":"3610_CR23","doi-asserted-by":"crossref","first-page":"7053","DOI":"10.1158\/1078-0432.CCR-07-1506","volume":"13","author":"DC Danila","year":"2007","unstructured":"Danila DC, Heller G, Gignac GA, Gonzalez-Espinoza R, Anand A, Tanaka E, Lilja H, Schwartz L, Larson S, Fleisher M, Scher HI (2007) Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer. Clin Cancer Res 13(23):7053\u20137058. doi: 10.1158\/1078-0432.CCR-07-1506","journal-title":"Clin Cancer Res"},{"issue":"19","key":"3610_CR24","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1200\/JCO.2007.15.8923","volume":"26","author":"SJ Cohen","year":"2008","unstructured":"Cohen SJ, Punt CJ, Iannotti N, Saidman BH, Sabbath KD, Gabrail NY, Picus J, Morse M, Mitchell E, Miller MC, Doyle GV, Tissing H, Terstappen LW, Meropol NJ (2008) Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J Clin Oncol 26(19):3213\u20133221. doi: 10.1200\/JCO.2007.15.8923","journal-title":"J Clin Oncol"},{"issue":"8","key":"3610_CR25","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1056\/NEJMoa040766","volume":"351","author":"M Cristofanilli","year":"2004","unstructured":"Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ, Terstappen LW, Hayes DF (2004) Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 351(8):781\u2013791","journal-title":"N Engl J Med"},{"issue":"33","key":"3610_CR26","doi-asserted-by":"crossref","first-page":"5194","DOI":"10.1200\/JCO.2007.11.7762","volume":"25","author":"M Ignatiadis","year":"2007","unstructured":"Ignatiadis M, Xenidis N, Perraki M, Apostolaki S, Politaki E, Kafousi M, Stathopoulos EN, Stathopoulou A, Lianidou E, Chlouverakis G, Sotiriou C, Georgoulias V, Mavroudis D (2007) Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer. J Clin Oncol 25(33):5194\u20135202. doi: 10.1200\/JCO.2007.11.7762","journal-title":"J Clin Oncol"},{"issue":"7","key":"3610_CR27","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S1470-2045(12)70209-7","volume":"13","author":"A Lucci","year":"2012","unstructured":"Lucci A, Hall CS, Lodhi AK, Bhattacharyya A, Anderson AE, Xiao L, Bedrosian I, Kuerer HM, Krishnamurthy S (2012) Circulating tumour cells in non-metastatic breast cancer: a prospective study. Lancet Oncol 13(7):688\u2013695. doi: 10.1016\/S1470-2045(12)70209-7","journal-title":"Lancet Oncol"},{"issue":"4","key":"3610_CR28","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S1470-2045(14)70069-5","volume":"15","author":"FC Bidard","year":"2014","unstructured":"Bidard FC, Peeters DJ, Fehm T, Nole F, Gisbert-Criado R, Mavroudis D, Grisanti S, Generali D, Garcia-Saenz JA, Stebbing J, Caldas C, Gazzaniga P, Manso L, Zamarchi R, de Lascoiti AF, De Mattos-Arruda L, Ignatiadis M, Lebofsky R, van Laere SJ, Meier-Stiegen F, Sandri MT, Vidal-Martinez J, Politaki E, Consoli F, Bottini A, Diaz-Rubio E, Krell J, Dawson SJ, Raimondi C, Rutten A, Janni W, Munzone E, Caranana V, Agelaki S, Almici C, Dirix L, Solomayer EF, Zorzino L, Johannes H, Reis-Filho JS, Pantel K, Pierga JY, Michiels S (2014) Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data. Lancet Oncol 15(4):406\u2013414. doi: 10.1016\/S1470-2045(14)70069-5","journal-title":"Lancet Oncol"},{"issue":"19","key":"3610_CR29","doi-asserted-by":"crossref","first-page":"6302","DOI":"10.1158\/1078-0432.CCR-08-0872","volume":"14","author":"JS Bono de","year":"2008","unstructured":"de Bono JS, Scher HI, Montgomery RB, Parker C, Miller MC, Tissing H, Doyle GV, Terstappen LW, Pienta KJ, Raghavan D (2008) Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin Cancer Res 14(19):6302\u20136309","journal-title":"Clin Cancer Res"},{"issue":"3","key":"3610_CR30","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1464-410X.2007.06659.x","volume":"99","author":"JA Garcia","year":"2007","unstructured":"Garcia JA, Rosenberg JE, Weinberg V, Scott J, Frohlich M, Park JW, Small EJ (2007) Evaluation and significance of circulating epithelial cells in patients with hormone-refractory prostate cancer. BJU Int 99(3):519\u2013524. doi: 10.1111\/j.1464-410X.2007.06659.x","journal-title":"BJU Int"},{"issue":"5","key":"3610_CR31","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1158\/1078-0432.CCR-14-1948","volume":"21","author":"MJ Magbanua","year":"2015","unstructured":"Magbanua MJ, Carey LA, DeLuca A, Hwang J, Scott JH, Rimawi MF, Mayer EL, Marcom PK, Liu MC, Esteva FJ, Park JW, Rugo HS, Translational Breast Cancer Research C (2015) Circulating tumor cell analysis in metastatic triple-negative breast cancers. Clin Cancer Res 21(5):1098\u20131105. doi: 10.1158\/1078-0432.CCR-14-1948","journal-title":"Clin Cancer Res"},{"issue":"1","key":"3610_CR32","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1158\/0008-5472.CAN-11-3017","volume":"73","author":"MJ Magbanua","year":"2013","unstructured":"Magbanua MJ, Sosa EV, Roy R, Eisenbud LE, Scott JH, Olshen A, Pinkel D, Rugo HS, Park JW (2013) Genomic profiling of isolated circulating tumor cells from metastatic breast cancer patients. Cancer Res 73(1):30\u201340. doi: 10.1158\/0008-5472.CAN-11-3017","journal-title":"Cancer Res"},{"issue":"9","key":"3610_CR33","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/neuonc\/nou089","volume":"16","author":"M Chamberlain","year":"2014","unstructured":"Chamberlain M, Soffietti R, Raizer J, Ruda R, Brandsma D, Boogerd W, Taillibert S, Groves MD, Le Rhun E, Junck L, van den Bent M, Wen PY, Jaeckle KA (2014) Leptomeningeal metastasis: a response assessment in neuro-oncology critical review of endpoints and response criteria of published randomized clinical trials. Neuro-oncology 16(9):1176\u20131185. doi: 10.1093\/neuonc\/nou089","journal-title":"Neuro-oncology"},{"issue":"10","key":"3610_CR34","doi-asserted-by":"crossref","first-page":"752","DOI":"10.18632\/oncotarget.336","volume":"2","author":"AS Patel","year":"2011","unstructured":"Patel AS, Allen JE, Dicker DT, Peters KL, Sheehan JM, Glantz MJ, El-Deiry WS (2011) Identification and enumeration of circulating tumor cells in the cerebrospinal fluid of breast cancer patients with central nervous system metastases. Oncotarget 2(10):752\u2013760","journal-title":"Oncotarget"},{"key":"3610_CR35","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1472-6890-12-21","volume":"12","author":"E Rhun Le","year":"2012","unstructured":"Le Rhun E, Massin F, Tu Q, Bonneterre J, Bittencourt Mde C, Faure GC (2012) Development of a new method for identification and quantification in cerebrospinal fluid of malignant cells from breast carcinoma leptomeningeal metastasis. BMC Clin Pathol 12:21. doi: 10.1186\/1472-6890-12-21","journal-title":"BMC Clin Pathol"},{"issue":"17","key":"3610_CR36","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1212\/WNL.0b013e31828f183f","volume":"80","author":"L Nayak","year":"2013","unstructured":"Nayak L, Fleisher M, Gonzalez-Espinoza R, Lin O, Panageas K, Reiner A, Liu CM, Deangelis LM, Omuro A (2013) Rare cell capture technology for the diagnosis of leptomeningeal metastasis in solid tumors. Neurology 80(17):1598\u20131605. doi: 10.1212\/WNL.0b013e31828f183f discussion 1603","journal-title":"Neurology"},{"issue":"5","key":"3610_CR37","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.cell.2014.07.013","volume":"158","author":"N Aceto","year":"2014","unstructured":"Aceto N, Bardia A, Miyamoto DT, Donaldson MC, Wittner BS, Spencer JA, Yu M, Pely A, Engstrom A, Zhu H, Brannigan BW, Kapur R, Stott SL, Shioda T, Ramaswamy S, Ting DT, Lin CP, Toner M, Haber DA, Maheswaran S (2014) Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell 158(5):1110\u20131122. doi: 10.1016\/j.cell.2014.07.013","journal-title":"Cell"},{"issue":"2","key":"3610_CR38","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ymeth.2013.07.029","volume":"64","author":"MJ Magbanua","year":"2013","unstructured":"Magbanua MJ, Park JW (2013) Isolation of circulating tumor cells by immunomagnetic enrichment and fluorescence-activated cell sorting (IE\/FACS) for molecular profiling. Methods 64(2):114\u2013118. doi: 10.1016\/j.ymeth.2013.07.029","journal-title":"Methods"},{"key":"3610_CR39","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1471-2407-12-78","volume":"12","author":"MJ Magbanua","year":"2012","unstructured":"Magbanua MJ, Sosa EV, Scott JH, Simko J, Collins C, Pinkel D, Ryan CJ, Park JW (2012) Isolation and genomic analysis of circulating tumor cells from castration resistant metastatic prostate cancer. BMC Cancer 12:78. doi: 10.1186\/1471-2407-12-78","journal-title":"BMC Cancer"},{"issue":"23","key":"3610_CR40","doi-asserted-by":"crossref","first-page":"7134","DOI":"10.1158\/0008-5472.CAN-13-2051","volume":"73","author":"MJ Magbanua","year":"2013","unstructured":"Magbanua MJ, Melisko M, Roy R, Sosa EV, Hauranieh L, Kablanian A, Eisenbud LE, Ryazantsev A, Au A, Scott JH, Park JW (2013) Molecular profiling of tumor cells in cerebrospinal fluid and matched primary tumors from metastatic breast cancer patients with leptomeningeal carcinomatosis. Cancer Res 73(23):7134\u20137143. doi: 10.1158\/0008-5472.CAN-13-2051","journal-title":"Cancer Res"},{"key":"3610_CR41","first-page":"109","volume":"1","author":"MJ Magbanua","year":"2014","unstructured":"Magbanua MJ, Melisko M, Park JW (2014) Molecular characterization of cerebrospinal fluid tumor cells associated with leptomeningeal carcinomatosis. Cancer Cell Microenviron 1:109\u2013113. doi: 10.14800\/ccm.167","journal-title":"Cancer Cell Microenviron"},{"key":"3610_CR42","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.gdata.2014.04.003","volume":"2","author":"MJ Magbanua","year":"2014","unstructured":"Magbanua MJ, Roy R, Sosa EV, Hauranieh L, Kablanian A, Eisenbud LE, Ryazantsev A, Au A, Scott JH, Melisko M, Park JW (2014) Genome-wide copy number analysis of cerebrospinal fluid tumor cells and their corresponding archival primary tumors. Genom Data 2:60\u201362. doi: 10.1016\/j.gdata.2014.04.003","journal-title":"Genom Data"},{"issue":"1","key":"3610_CR43","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.clineuro.2012.03.048","volume":"115","author":"JA Palma","year":"2013","unstructured":"Palma JA, Fernandez-Torron R, Esteve-Belloch P, Fontes-Villalba A, Hernandez A, Fernandez-Hidalgo O, Gallego Perez-Larraya J, Martinez-Vila E (2013) Leptomeningeal carcinomatosis: prognostic value of clinical, cerebrospinal fluid, and neuroimaging features. Clin Neurol Neurosurg 115(1):19\u201325. doi: 10.1016\/j.clineuro.2012.03.048","journal-title":"Clin Neurol Neurosurg"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-015-3610-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-015-3610-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-015-3610-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T12:43:17Z","timestamp":1559220197000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-015-3610-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,31]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["3610"],"URL":"https:\/\/doi.org\/10.1007\/s10549-015-3610-1","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,31]]}}}